HK Stock MarketDetailed Quotes
06978 IMMUNOTECH-B
- 2.160
- 0.0000.00%
Not Open Nov 29 16:08 CST
1.11BMarket Cap-3282P/E (TTM)
2.250High2.100Low252.00KVolume2.240Open2.160Pre Close542.79KTurnover0.05%Turnover RatioLossP/E (Static)514.58MShares5.00052wk High12.49P/B1.11BFloat Cap1.50052wk Low--Dividend TTM514.58MShs Float22.450Historical High--Dividend LFY6.94%Amplitude1.500Historical Low2.153Avg Price1000Lot Size--Div YieldTTM--Div Yield LFY
IMMUNOTECH-B Key Stats
EPS
According to the latest financial report of IMMUNOTECH-B, the latest earnings per share (TTM) for the company is -0.20. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: HKD
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out IMMUNOTECH-B's latest financial report to see how much their book value per share (BVPS) is currently at 0.17.
Currency: HKD
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of IMMUNOTECH-B shows that the company's current ratio is 0.38, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of IMMUNOTECH-B, the quick ratio is 27.83, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of IMMUNOTECH-B? The latest ROE figure is -72.29%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of IMMUNOTECH-B, the total asset return on investment (ROA) is -11.77%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check IMMUNOTECH-B's latest financial report to see how their gross margin is doing - currently at --.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of IMMUNOTECH-B, the net profit margin is --, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data